AAAAAA
Results: 1-25/27
Authors:
Zessin, J
Eskola, O
Brust, P
Bergman, J
Steinbach, J
Lehikoinen, P
Solin, O
Johannsen, B
Citation: J. Zessin et al., Synthesis of S-([F-18]fluoromethyl)-(+)-McN5652 as a potential PET radioligand for the serotonin transporter, NUCL MED BI, 28(7), 2001, pp. 857-863
Authors:
Bergman, J
Eskola, O
Lehikoinen, P
Solin, O
Citation: J. Bergman et al., Automated synthesis and purification of [F-18]bromofluoromethane at high specific radioactivity, APPL RAD IS, 54(6), 2001, pp. 927-933
Authors:
Laakso, A
Bergman, J
Haaparanta, M
Vilkman, H
Solin, O
Syvalahti, E
Hietala, J
Citation: A. Laakso et al., Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia, SCHIZOPHR R, 52(1-2), 2001, pp. 115-120
Authors:
Rinne, JO
Nurmi, E
Ruottinen, HM
Bergman, J
Eskola, O
Solin, O
Citation: Jo. Rinne et al., [F-18]FDOPA and [F-18]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease, SYNAPSE, 40(3), 2001, pp. 193-200
Authors:
Ruottinen, HM
Niinivirta, M
Bergman, J
Oikonen, V
Solin, O
Eskola, O
Eronen, E
Sonninen, P
Rinne, UK
Citation: Hm. Ruottinen et al., Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging, SYNAPSE, 40(1), 2001, pp. 19-26
Authors:
Nurmi, E
Ruottinen, HM
Bergman, J
Haaparanta, M
Solin, O
Sonninen, P
Rinne, JO
Citation: E. Nurmi et al., Rate of progression in Parkinson's disease: A 6-[F-18]fluoro-L-dopa PET study, MOVEMENT D, 16(4), 2001, pp. 608-615
Authors:
Bruck, A
Portin, R
Lindell, A
Laihinen, A
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
Citation: A. Bruck et al., Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus, NEUROSCI L, 311(2), 2001, pp. 81-84
Authors:
Gronroos, T
Eskola, I
Lehtio, K
Minn, H
Marjamaki, P
Bergman, J
Haaparanta, M
Forsback, S
Solin, O
Citation: T. Gronroos et al., Pharmacokinetics of [F-18]FETNIM: A potential hypoxia marker for PET, J NUCL MED, 42(9), 2001, pp. 1397-1404
Authors:
Lehtio, K
Oikonen, V
Gronroos, T
Eskola, O
Kalliokoski, K
Bergman, J
Solin, O
Grenman, R
Nuutila, P
Minn, H
Citation: K. Lehtio et al., Imaging of blood flow and hypoxia in head and neck cancer: Initial evaluation with [O-15]H2O and [F-18]fluoroerythronitroimidazole PET, J NUCL MED, 42(11), 2001, pp. 1643-1652
Authors:
Kaasinen, V
Nurmi, E
Bergman, J
Eskola, O
Solin, O
Sonninen, P
Rinne, JO
Citation: V. Kaasinen et al., Personality traits and brain dopaminergic function in Parkinson's disease, P NAS US, 98(23), 2001, pp. 13272-13277
Authors:
Kaasinen, V
Nurmi, E
Bruck, A
Bergman, J
Solin, O
Rinne, JO
Citation: V. Kaasinen et al., Increased frontal [F-18]fluorodopa uptake in early Parkinson's Disease: sex differences in the prefrontal cortex, BRAIN, 124, 2001, pp. 1125-1130
Authors:
Lapela, M
Eigtved, A
Jyrkkio, S
Grenman, R
Kurki, T
Lindholm, P
Nuutinen, J
Sutinen, E
Solin, O
Bjornskov, I
Bretlau, P
Friberg, L
Holm, S
Jensen, M
Hansen, HS
Minn, H
Citation: M. Lapela et al., Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer, EUR J CANC, 36(7), 2000, pp. 858-867
Authors:
Nurmi, E
Ruottinen, HM
Kaasinen, V
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
Citation: E. Nurmi et al., Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT, ANN NEUROL, 47(6), 2000, pp. 804-808
Authors:
Laihinen, A
Ruottinen, H
Rinne, JO
Haaparanta, M
Bergman, J
Solin, O
Koskenvuo, M
Marttila, R
Rinne, UK
Citation: A. Laihinen et al., Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [F-18]6-fluorodopa PET, J NEUROL, 247, 2000, pp. 110-113
Authors:
Nurmi, E
Bergman, J
Eskola, O
Solin, O
Hinkka, SM
Sonninen, P
Rinne, JO
Citation: E. Nurmi et al., Reproducibility and effect of levodopa on dopamine transporter function measurements: A [F-18]CFT PET study, J CEREBR B, 20(11), 2000, pp. 1604-1609
Authors:
Ruottinen, HM
Partinen, M
Hublin, C
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
Citation: Hm. Ruottinen et al., An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome, NEUROLOGY, 54(2), 2000, pp. 502-504
Authors:
Kahkonen, M
Metsahonkala, L
Minn, H
Utriainen, T
Korhonen, T
Norvasuo-Heila, MK
Harila-Saari, A
Aarimaa, T
Suhonen-Polvi, H
Ruotsalainen, U
Solin, O
Salmi, TT
Citation: M. Kahkonen et al., Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia, CANCER, 88(3), 2000, pp. 693-700
Authors:
DeJesus, OT
Haaparanta, M
Solin, O
Nickles, RJ
Citation: Ot. Dejesus et al., 6-FluoroDOPA metabolism in rat striatum: time course of extracellular metabolites, BRAIN RES, 877(1), 2000, pp. 31-36
Authors:
Rinne, JO
Portin, R
Ruottinen, H
Nurmi, E
Bergman, J
Haaparanta, M
Solin, O
Citation: Jo. Rinne et al., Cognitive impairment and the brain dopaminergic system in Parkinson disease - [F-18]fluorodopa positron emission tomographic study, ARCH NEUROL, 57(4), 2000, pp. 470-475
Authors:
Salokangas, RKR
Vilkman, H
Ilonen, T
Taiminen, T
Bergman, J
Haaparanta, M
Solin, O
Alanen, A
Syvalahti, E
Hietala, J
Citation: Rkr. Salokangas et al., High levels of dopamine activity in the basal ganglia of cigarette smokers, AM J PSYCHI, 157(4), 2000, pp. 632-634
Authors:
Laakso, A
Vilkman, H
Alakare, B
Haaparanta, M
Bergman, J
Solin, O
Peurasaari, J
Rakkolainen, V
Syvalahti, E
Hietala, J
Citation: A. Laakso et al., Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography, AM J PSYCHI, 157(2), 2000, pp. 269-271
Authors:
Laakso, A
Vilkman, H
Kajander, J
Bergman, J
Haaparanta, M
Solin, O
Hietala, J
Citation: A. Laakso et al., Prediction of detached personality in healthy subjects by low dopamine transporter binding, AM J PSYCHI, 157(2), 2000, pp. 290-292
Authors:
Hietala, J
Syvalahti, E
Vilkman, H
Vuorio, K
Rakkolainen, V
Bergman, J
Haaparanta, M
Solin, O
Kuoppamaki, M
Eronen, E
Ruotsalainen, U
Salokangas, RKR
Citation: J. Hietala et al., Depressive symptoms and presynaptic dopamine function in neuroleptic-naiveschizophrenia, SCHIZOPHR R, 35(1), 1999, pp. 41-50
Authors:
Rinne, JO
Bergman, J
Ruottinen, H
Haaparanta, M
Eronen, E
Oikonen, V
Sonninen, P
Solin, O
Citation: Jo. Rinne et al., Striatal uptake of a novel PET ligand, [F-18]beta-CFT, is reduced in earlyParkinson's disease, SYNAPSE, 31(2), 1999, pp. 119-124
Authors:
Suhonen-Polvi, H
Varho, T
Metsahonkala, L
Haataja, L
Ruotsalainen, U
Haaparanta, M
Bergman, J
Solin, O
Aarimaa, T
Holopainen, I
Vainionpaa, L
Manner, T
Jaaskelainen, S
Renlund, M
Sillanpaa, M
Aula, P
Citation: H. Suhonen-polvi et al., Increased brain glucose utilization in Salla disease (free sialic acid storage disorder), J NUCL MED, 40(1), 1999, pp. 12-18